The study on the preparation and spectroscopic properties of hydroxypropyl-β-cyclodextrin/glipizide inclusion complex

Guang Pu Xue Yu Guang Pu Fen Xi/Spectroscopy and Spectral Analysis

Volumn 28, Issue 3, 2008, Pages 711-714

  Zhang, Yi Min ^a   Li, Xiao ^a   Sun, Cong Shan ^a   Chen, Chun Feng ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Glipizide; Hydroxypropyl cyclodextrin; Inclusion complex; IR; XRD

Indexed keywords

AMORPHOUS MATERIALS; CYCLODEXTRINS; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; INCLUSIONS; MOLECULAR INTERACTIONS; SOLUBILITY; STABILITY; X RAY DIFFRACTION;

GLIPIZIDE; HYDROXYPROPYL-BETA-CYCLODEXTRIN; INCLUSION COMPLEX; SPECTROSCOPIC PROPERTIES; STABILITY CONSTANT;

METAL COMPLEXES;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; GLIPIZIDE;

ARTICLE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROSCOPY; METHODOLOGY; SOLUBILITY; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; GLIPIZIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 42949177494     PISSN: 10000593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Patel J K, Pakesh P P, Amin A F, et al. AAPS. Pharm. Sci. Tech., 2005, 6 (1): 49.
2. Echezarreta-Lopez M, Torres-Labandeira J J, Castineiras-Seijo L, et al. Eur. J. Pharm. Sci., 2000, 9: 381.
3. Liu Y, Chen G S, Chen Y, et al. Bioorg. Med. Chem., 2005, 13: 4037.
4. Challa R, Ahuja A, Ali J, et al. AAPS. Pharm. Sci. Tech., 2005, 6 (2): 329.
5. FENG Guang-zhu, LU Kui, LI He-ping. Spectroscopy and Spectral Analysis, 2004, 24 (9): 1099.
6. Beker O, Uijtendaal E V, Beijnen J H, et al. Drug Dev. Ind Pharm., 1991, 17 (11): 1503.
7. Liu Y, Zhang Y M, Sun S X, et al. J. Chem. Soc. Perkin Trans., 2, 1997, 8: 1609.
8. Qu Q, Tucker E, Christian S D. J. Inclusion Phenom., 2002, 43 (3-4): 213.
9. ZHANG Yi-min, ZHANG Zhi-fei, ZHOU Qin, et al. Chinese J. Anal. Chem., 2006, 34 (5): 713.
10. Suihko E, Korhonen O, Jarvinen T, et al. Int J. Pharm., 2001, 215: 137.
11. Szente L, Szejtli J. Adv. Drug. Delivery Rev., 1999, 36: 17.
12. Esclusa-Diaz M T, Torres-Labandeira J J, Kata M. Eur. J. Pharm. Sci., 1994, 1: 291.
13. Veiga F, Femandes C, Teixeira F. Int J. Pharm., 2000, 202: 165.
14. Higuchi T, Connors K A. Adv. Anal. Chem. Instr., 1965, 4: 212.
15. Baboota S, Dhaliwal M, Kohli K. AAPS. Pharm Sci. Tech., 2005, 6 (1): 83.
16. Pose-Vilarnovo P, Perdomo-lopez I, Echezarreta-Lopez, et al. Eur. J. Pharm. Sci., 2001, 13 (3): 325.
17. Verma R K, Garg S. J. Pharm Biomed. Anal., 2005, 38: 633.
18. Ammar H O, Salama H A, Ghorab M, et al. Int. J. Pharm., 2006, 309: 129.
19. Ozkan Y, Atay T, Dikmen N, et al. Pharm. Acta Helv., 2000, 74: 365.
20. Babu R J, Pandit J K. Int. J. Pharm, 2004, 271: 155.
21. ZHANG Jing, LIU Wan-yi, ZHANG Xia. Spectroscopy and Spectral Analysis, 2006, 26 (3): 517.